… Plasma therapy has also been authorised for emergency use for the treatment of COVID-19
on a … It is concluded that a suitable candidate delivered through an advanced drug delivery …

… key discussion points, and provides an overview of potential future treatment targets and
drug delivery systems. Treatment of long-COVID-19 is not within the focus of this review. …

… deliver them safely and efficiently to their therapeutic targets. Second, the drug carriers can
be tailored to develop smart delivery … stimuli to release the anti-COVID-19 therapeutics in a …

… In the medical sector, the applications of vesicular-delivery systems will prove to be very …
therapeutic and diagnostic approaches to COVID-19 [18]. Theranostics with vesicular-delivery …

… and therapeutic … drug delivery strategies for future fights against new viral pathogens. In
this manuscript, a group of leading drug delivery scientists share perspectives on drug delivery …

… , 19 Convalescent plasma therapy may also help improve outcomes in patients with severe
COVID‐19, … , 21 There are also a number of postinfection therapeutics being evaluated in the …

… all aspects of COVID-19 therapeutics. We explore challenges that have stymied COVID-19
drug development and highlight important unmet needs. We examine key therapeutic classes …

… syndrome coronavirus 2 (SARS‑CoV‑2) which is the primary causative organism that had
led to the current COVID-19 pandemic. We address existing as well as emerging therapeutic …

… -19 pandemic. There is no current standard of care. Clinicians need to be mindful of the …
or repurposed to treat COVID-19. The United States Food and Drug Administration (FDA) has …

… While oral therapy is accepted as an effective and simple … administration routs. Only studies
were included in this review that aimed at pulmonary drug delivery for treatment of COVID-19…